NEW BRUNSWICK, NJ - A Rutgers University-led team, that includes two other major New Jersey higher education institutions, has been awarded a $29 million grant from the National Institute of Health (NIH) to develop patient treatments based on results found in laboratories as well as in clinics, Rutgers announced.
The five-year grant was awarded to the Rutgers Institute for Translational Medicine and Science, which also involves Princeton University and the New Jersey Institute of Technology. The schools will also make financial contributions to the program, bringing the total amount of funding to $45 million, Rutgers officials said in a statement.
The university described the awkward sounding translational science as taking observations made in the laboratories, clinics and community settings, and creating interventions to improve the health of individuals and populations.
This involves everything from diagnostics and therapeutics to medical procedures and behavioral interventions, the university said.
“The ultimate goal is bringing more evidence-based treatments to more patients more quickly,” said Reynold Panettieri, vice chancellor for Translational Medicine and Science and director of Rutgers Institute for Translational Medicine and Science (RITMS).
The award is part of the NIH Clinical and Translational Science Awards Program (CTSA).
The program at Rutgers will be known as NJ ACTS, or New Jersey Alliance for Clinical and Translational Science.
Rutgers and its partner schools will build a new infrastructure for research across the state aimed at giving patients access to clinical trials with the latest methods of care. Also, the program will analyze data to discover trends in population health that can inform basic science research.
The program will involve the Adult Clinical Research and Pediatric Clinical Research Unit at Rutgers Robert Wood Johnson Medical School and centers based at Rutgers New Jersey Medical School, Rutgers School of Dental Medicine, and Rutgers Environmental and Occupational Health Sciences Institute.
“It would not have been possible without the combination of resources from these two large great universities as well as the funding provided through our partnership with RWJBarnabas Health," said Brian Strom, chancellor of Rutgers Biomedical and Health Sciences and executive vice president of the university's Health Affairs.
"It indicates to the world and to New Jersey industry that New Jersey is now in the big leagues of academic clinical research,” Strom said.
The award was granted on the strong partnership of Rutgers, Princeton, and NJIT, as well as the partnerships with community-based organizations, hospitals, community health centers, and data centers, Rutgers officials said.